Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 7.85B | 7.93B | 6.59B | 6.40B | 7.99B |
Gross Profit | 1.52B | 1.40B | 1.42B | 1.34B | 1.21B |
EBITDA | 514.62M | 445.94M | 676.64M | 557.38M | 200.02M |
Net Income | 38.03M | 37.35M | 254.87M | 166.19M | -234.92M |
Balance Sheet | |||||
Total Assets | 14.04B | 13.83B | 12.70B | 11.51B | 11.77B |
Cash, Cash Equivalents and Short-Term Investments | 723.92M | 1.60B | 2.21B | 2.56B | 2.65B |
Total Debt | 1.84B | 1.44B | 1.51B | 1.18B | 998.77M |
Total Liabilities | 5.08B | 4.86B | 4.59B | 3.70B | 4.09B |
Stockholders Equity | 8.96B | 8.97B | 8.11B | 7.81B | 7.68B |
Cash Flow | |||||
Free Cash Flow | -929.49M | 101.98M | -12.94M | -186.11M | 610.78M |
Operating Cash Flow | -532.91M | 280.57M | 445.28M | 138.03M | 882.11M |
Investing Cash Flow | -307.21M | -735.99M | -726.35M | -242.51M | -276.02M |
Financing Cash Flow | 37.09M | -154.12M | -34.27M | 18.89M | 278.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | £2.83B | 10.37 | 4.69% | 3.46% | 2.40% | -24.53% | |
67 Neutral | ¥3.30B | 89.92 | 1.17% | -1.11% | 2.09% | ||
$1.88B | 4.32 | 24.36% | <0.01% | ― | ― | ||
€1.22B | 7.53 | 28.11% | 1.00% | ― | ― | ||
78 Outperform | ¥9.52B | 7.93 | 2.67% | 7.08% | 165.25% | ||
73 Outperform | ¥4.05B | 16.02 | 2.05% | 18.87% | -0.18% | ||
68 Neutral | ¥9.49B | 9.34 | 0.71% | -3.74% | -55.02% |